Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Cancer Health Center

Font Size

FDA OKs New Kidney Cancer Drug

Afinitor Approved for Advanced Kidney Cancer That Progresses Despite Other Treatment
WebMD Health News
Reviewed by Louise Chang, MD

April 2, 2009 -- The FDA has approved a new drug called Afinitor to treat advanced renal cell carcinoma after other treatments fail. Renal cell carcinoma is the most common type of kidney cancer.

Afinitor (everolimus) is taken orally. It's part of a class of drugs called kinase inhibitors, which interfere with cell communication to prevent tumor growth.

The FDA approved Afinitor for advanced renal cell carcinoma patients who have already tried another kinase inhibitor -- Sutent or Nexavar.

The FDA based its decision on a clinical trial that was discontinued when interim results showed that the growth or spread of the tumor was delayed in patients taking Afinitor.

In that trial, half of the patients taking Afinitor also had slower worsening of their kidney cancer; their disease progressed after about five months, compared to two months in patients who didn't receive the drug.

The most frequent side effects in the trial included inflammation in the mouth, loss of strength, diarrhea, poor appetite, fluid buildup in the extremities, shortness of breath, coughing, nausea, vomiting, rash, and fever.

Lab tests also showed that at least half of all patients experienced anemia, low white blood cell counts, high cholesterol, high triglycerides, and high blood sugar, according to the FDA.

Afinitor is made by the drug company Novartis.

Today on WebMD

Colorectal cancer cells
New! I AM Not Cancer Facebook Group
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Real Cancer Perspectives
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas